Target intelligence / Profile preview

Histidine ammonia-lyase (HAL)

Target
HAL
Molecular classification
Enzyme, Lyase, Ammonia-lyase family
01

Overview

Histidine ammonia-lyase is a cytosolic enzyme that catalyzes the first step in the catabolism of the amino acid histidine, specifically the nonoxidative deamination of L-histidine to produce ammonia and trans-urocanic acid[1][3][5]. This reaction is essential for histidine degradation in humans and other organisms. HAL is a homotetramer with a unique autocatalytically formed MIO (3,5-dihydro-5-methylidene-4H-imidazol-4-one) cofactor at its active site, which is critical for its catalytic activity[2][4][5]. Mutations in the HAL gene result in histidinemia, an inborn error of metabolism characterized by elevated levels of histidine in blood and urine[1][7]. The enzyme is a member of the aromatic amino acid lyase family and structurally related to phenylalanine ammonia-lyase[3][5][6]. HAL plays a pivotal role in nitrogen metabolism and can serve as a biomarker for metabolic conditions affecting histidine degradation.

Other names
HistidaseHSTDHIShistidinaseL-histidine ammonia-lyase (urocanate-forming)
02

Biological functions

Amino acid metabolismCatalysis of nonoxidative deamination of L-histidineRegulation of histidine catabolism
03

Disease associations

Inborn errors of metabolism (e.g., histidinemia)Other (pathological accumulation of histidine or intermediates)
04

Safety considerations

Deficiency causes histidinemia (benign in most, but may be associated with developmental delay or learning disabilities if untreated)No known direct safety concerns for enzyme inhibition/augmentation in therapeutic context
05

Biomarkers

Urocanic acid levels (for monitoring enzyme activity or deficiency)Histidinemia (elevated plasma histidine, diagnostic marker)

Beyond the preview

Go deeper on Histidine ammonia-lyase (HAL).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Histidine ammonia-lyase (HAL).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call